Anticanceragent 275 exhibits significant anti-proliferative activity against BT12 cells. This compound may be utilized in research on rare and aggressive atypical teratoid/rhabdoid tumors (ATRT) as well as other cancer cell lines.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
